Bangladesh
· Delayed Price · Currency is BDT Navana Pharmaceuticals Statistics
Total Valuation
DSE:NAVANAPHAR has a market cap or net worth of BDT 5.22 billion. The enterprise value is 9.95 billion.
| Market Cap | 5.22B |
| Enterprise Value | 9.95B |
Important Dates
The next estimated earnings date is Tuesday, October 21, 2025.
| Earnings Date | Oct 21, 2025 |
| Ex-Dividend Date | Nov 20, 2024 |
Share Statistics
DSE:NAVANAPHAR has 107.42 million shares outstanding. The number of shares has decreased by -0.12% in one year.
| Current Share Class | 107.42M |
| Shares Outstanding | 107.42M |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | -0.78% |
| Owned by Insiders (%) | 35.49% |
| Owned by Institutions (%) | n/a |
| Float | 69.30M |
Valuation Ratios
The trailing PE ratio is 11.65.
| PE Ratio | 11.65 |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | 9.88 |
| P/OCF Ratio | 3.19 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.17, with an EV/FCF ratio of 18.84.
| EV / Earnings | 22.22 |
| EV / Sales | 1.18 |
| EV / EBITDA | 6.17 |
| EV / EBIT | 7.38 |
| EV / FCF | 18.84 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 1.02.
| Current Ratio | 0.89 |
| Quick Ratio | 0.17 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 3.08 |
| Debt / FCF | 9.41 |
| Interest Coverage | 1.84 |
Financial Efficiency
Return on equity (ROE) is 9.54% and return on invested capital (ROIC) is 8.75%.
| Return on Equity (ROE) | 9.54% |
| Return on Assets (ROA) | 7.74% |
| Return on Invested Capital (ROIC) | 8.75% |
| Return on Capital Employed (ROCE) | 25.61% |
| Revenue Per Employee | 1.92M |
| Profits Per Employee | 101,627 |
| Employee Count | 4,408 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 1.89 |
Taxes
In the past 12 months, DSE:NAVANAPHAR has paid 129.95 million in taxes.
| Income Tax | 129.95M |
| Effective Tax Rate | 22.49% |
Stock Price Statistics
The stock price has decreased by -46.48% in the last 52 weeks. The beta is -0.19, so DSE:NAVANAPHAR's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -46.48% |
| 50-Day Moving Average | 51.62 |
| 200-Day Moving Average | 52.58 |
| Relative Strength Index (RSI) | 44.13 |
| Average Volume (20 Days) | 190,079 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:NAVANAPHAR had revenue of BDT 8.47 billion and earned 447.97 million in profits. Earnings per share was 4.17.
| Revenue | 8.47B |
| Gross Profit | 3.87B |
| Operating Income | 1.35B |
| Pretax Income | 577.92M |
| Net Income | 447.97M |
| EBITDA | 1.52B |
| EBIT | 1.35B |
| Earnings Per Share (EPS) | 4.17 |
Balance Sheet
The company has 200.07 million in cash and 4.97 billion in debt, giving a net cash position of -4.73 billion or -44.06 per share.
| Cash & Cash Equivalents | 200.07M |
| Total Debt | 4.97B |
| Net Cash | -4.73B |
| Net Cash Per Share | -44.06 |
| Equity (Book Value) | 4.87B |
| Book Value Per Share | 45.32 |
| Working Capital | -667.88M |
Cash Flow
In the last 12 months, operating cash flow was 1.63 billion and capital expenditures -1.11 billion, giving a free cash flow of 528.31 million.
| Operating Cash Flow | 1.63B |
| Capital Expenditures | -1.11B |
| Free Cash Flow | 528.31M |
| FCF Per Share | 4.92 |
Margins
Gross margin is 45.69%, with operating and profit margins of 15.92% and 5.29%.
| Gross Margin | 45.69% |
| Operating Margin | 15.92% |
| Pretax Margin | 6.82% |
| Profit Margin | 5.29% |
| EBITDA Margin | 17.97% |
| EBIT Margin | 15.92% |
| FCF Margin | 6.24% |
Dividends & Yields
This stock pays an annual dividend of 1.40, which amounts to a dividend yield of 2.88%.
| Dividend Per Share | 1.40 |
| Dividend Yield | 2.88% |
| Dividend Growth (YoY) | 7.69% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 10.63% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 3.00% |
| Earnings Yield | 8.58% |
| FCF Yield | 10.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DSE:NAVANAPHAR has an Altman Z-Score of 1.84 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.84 |
| Piotroski F-Score | 6 |